DarlingIngredients (DAR) Q2 2025 earnings review

Core Business Shines but DGD Weakness Forces Major Guidance Cut

Darling's Q2 results revealed a stark divergence: the core ingredients business performed strongly, led by an 11% YoY increase in Feed EBITDA on the back of rising fat prices. However, this strength was completely overshadowed by persistent weakness in the Diamond Green Diesel (DGD) joint venture, where profits remain severely depressed compared to last year. The key event was a significant cut to full-year 2025 Combined Adjusted EBITDA guidance to $1.05-$1.10 billion, down from $1.25-$1.30 billion previously. This signals that the anticipated recovery in the renewable fuels market will be much slower and weaker than management expected just three months ago.

๐Ÿ‚ Bull Case

Core Business Strength

The core ingredients business (ex-DGD) is performing well, with EBITDA growing to $207M from $197M YoY. The Feed segment was a standout, with EBITDA up 11% driven by rising domestic fat prices, providing a stable cash flow base.

Capital Discipline

Management is executing on its deleveraging plan. The preliminary leverage ratio improved significantly to 3.34x from 3.93x at the end of FY24, strengthening the balance sheet amid market volatility.

๐Ÿป Bear Case

Material Guidance Reduction

The company cut its full-year Combined Adjusted EBITDA guidance by approximately $200 million at the midpoint. This is a significant negative revision that implies a much weaker second half than previously communicated.

DGD Profitability Collapse

Darling's share of DGD's EBITDA was only $42.6 million, down 44% from $76.6 million a year ago. The renewable fuels segment remains highly challenged by regulatory uncertainty and margin pressure, directly impacting Darling's bottom line.

โš–๏ธ Verdict: ๐Ÿ”ด

Bearish. The material reduction in full-year guidance is the most important takeaway and significantly outweighs the stability of the core business. While the core Feed segment is performing well, the company's earnings power remains highly exposed to the volatile and policy-dependent renewable fuels market, where the anticipated recovery has been delayed and diminished.

Key Themes

CONCERN๐Ÿ”ด๐Ÿ”ด

DGD Weakness Forces Substantial Guidance Cut

The primary drag on performance is the Diamond Green Diesel JV. Darling's share of DGD's EBITDA fell to $42.6M from $76.6M YoY. This weakness forced management to cut full-year Combined Adjusted EBITDA guidance from a midpoint of $1.275B to $1.075B. Management attributes the weakness to the regulatory overhang from Small Refinery Exemptions (SREs) and delayed RIN compliance, which is suppressing renewable fuel margins. This directly contradicts the narrative from just three months ago that DGD was past its trough and poised for a sharp rebound.

DRIVER๐ŸŸข

Feed Segment Remains a Bright Spot

The Feed Ingredients segment continues to show strength, with Segment Adjusted EBITDA increasing 11.3% YoY to $135.9M on flat sales. Management cites rising domestic fat prices as the key driver, supported by public policies favoring domestic feedstock for renewable fuels. This segment provides a crucial and stable cash flow source that partially offsets the extreme volatility from the DGD joint venture.

CONCERN๐Ÿ”ด

Renewable Fuel Market Recovery Delayed

Management signaled that the recovery in the renewable fuel market remains challenged. DGD-1 remains offline until margins improve, and DGD-3 is scheduled for a maintenance turnaround in Q3. This indicates that while management hopes for a better 2026, near-term production and profitability will remain constrained by weak market conditions and operational downtime.

DRIVER๐ŸŸข

Strategic Push into High-Margin Health Ingredients

Darling is advancing its strategic agenda in the higher-margin Food segment. The company signed a non-binding term sheet to form 'Nextida', a global collagen JV, to accelerate growth in the health and wellness market. Additionally, its new 'Nextida GC' glucose control peptide is seeing repeat orders and undergoing further scientific validation, representing a shift toward patented, value-added products.

DRIVER๐ŸŸข

Deleveraging Remains a Key Priority

The company continues to prioritize balance sheet health. In Q2, it refinanced and upsized its Eurobond and replaced term loans, locking in borrowing costs and enhancing flexibility. The preliminary leverage ratio improved to 3.34x from 3.93x at year-end 2024, demonstrating a commitment to using cash flow to reduce debt even in a difficult earnings environment.

Other KPIs

Core Business Performance (ex-DGD)$206.9 million Adjusted EBITDA

Stable. Darling's core operations (Feed, Food, and base Fuel segments) generated $206.9M in Adjusted EBITDA, up 5% from $196.9M in Q2 2024. This highlights the underlying health of the ingredients business, which is currently being masked by the severe downturn in the DGD joint venture.

Gross Margin23.3%

Improving. Gross margin expanded from 22.5% in Q2 2024, reflecting the positive pricing environment in the Feed segment and effective cost management. This improvement in the core business's profitability is a positive sign.

Balance Sheet Health3.34x Leverage Ratio

Improving. The company successfully lowered its leverage ratio from 3.93x at the end of FY24. Total debt outstanding was reduced to $3.98 billion from $4.04 billion over the same period, demonstrating progress on its capital allocation priority to strengthen the balance sheet.

Guidance

FY25 Combined Adjusted EBITDA$1.05 - $1.10 billion

Decelerating significantly vs. prior outlook. This new range is a substantial reduction from the $1.25 - $1.30 billion guided in Q1. The midpoint was lowered by $200M, or approximately 16%. The company's view of its full-year earnings power has materially weakened in just three months.

Implied H2 2025 Performance~$315 million EBITDA per quarter

Requires acceleration. With $445.3M in EBITDA generated in H1, the new guidance implies the company must generate ~$630M in H2. This requires a quarterly run-rate of approximately $315M, a significant step-up from Q2's $249.5M and Q1's $195.8M, indicating management still expects a strong sequential recovery.